Research on revision of origins to Chinese medicinal materials in 2020 edition of Chinese pharmacopoeia.
10.19540/j.cnki.cjcmm.20210226.104
- Author:
Wei-Liang ZHAO
1
;
Ze YI
2
;
Qin-Wei HUANG
2
;
Jian-Liang ZHOU
1
;
Shi-Lin CHEN
3
Author Information
1. College of Pharmacy, Hangzhou Normal University Hangzhou 311121, China Zhejiang Institute for Food and Drug Control Hangzhou 310052, China.
2. Zhejiang Institute for Food and Drug Control Hangzhou 310052, China.
3. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
Alismatis Rhizoma;
Cassiae Semen;
Cera Chinensis;
Chinese pharmacopoeia;
Coicis Semen;
Corydalis Bungeanae Herba;
Echinopsis Radix;
revision of origins
- MeSH:
Animals;
China;
Coix;
Drugs, Chinese Herbal;
Medicine, Chinese Traditional;
Rhizome
- From:
China Journal of Chinese Materia Medica
2021;46(10):2617-2622
- CountryChina
- Language:Chinese
-
Abstract:
The origins of 9 species of the Chinese medicinal materials in the 2015 edition of the Chinese pharmacopoeia(ChP) has revised in the 2020 edition of ChP. The revision is based on the investigation and textual research on the problems found after screening the original plants, animals or minerals of all the Chinese medicinal materials in the 2015 edition. Among them the Chinese names of Alismatis Rhizoma, Cassiae Semen, Coicis Semen, Corydalis Bungeanae Herba and Echinopsis Radix all do not match to the Latin scientific names, and also do not match the name of the actual medicinal origins. In addition, Alismatis Rhizoma has the omission of original plant. There is confusion about the Chinese name and the family name of the original insect of Cera Chinensis. The original mineral of Gypsum Fibrosum has the wrong group names. Alumstone and melanterite, the original mineral of Alumen and Melanteritum respectively, of which the group names are missing. To solve these problems, field survey and literature research were conducted on the medicinal materials and their origins. The source of these problems are explored. The correct origins and the Chinese names or Latin names are all determined according to the research results to the situation, in which the Chinese and Latin names of the original plants of the medicinal materials do not match. The correct family name and group name are obtained through textual research by taxonomy if the names are confused or mis-sing. The scientific evidence and correct results of revision in the 2020 edition of ChP are determined at last.
